Exercising 'veto' power to make haploidentical hematopoietic stem cell transplantation a safe modality for induction of immune tolerance (Q48039446)

7 February 2018

editorial

0 references

title

Exercising 'veto' power to make haploidentical hematopoietic stem cell transplantation a safe modality for induction of immune tolerance (English)

1 reference

7 February 2018

author

Noga Or-Geva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933232%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Yair Reisner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933232%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Noga Or-Geva

1

1 reference

7 February 2018

Yair Reisner

2

1 reference

7 February 2018

publication date

1 January 2015

1 reference

7 February 2018

published in

Regenerative Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933232%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933232%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933232%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

239-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25933232%20AND%20SRC:MED&resulttype=core&format=json

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

10 June 2020

cites work

1 reference

Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.

21 January 2018

1 reference

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning

21 January 2018

1 reference

Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

21 January 2018

1 reference

Haploidentical hematopoietic transplantation: current status and future perspectives

21 January 2018

1 reference

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

21 January 2018

1 reference

Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.

21 January 2018

1 reference

Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host anti-donor memory effector cells.

21 January 2018

1 reference

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

21 January 2018

1 reference

Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts.

21 January 2018

1 reference

Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants

21 January 2018

1 reference